Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06151145
Other study ID # IRB00404188
Secondary ID R01NR020197
Status Recruiting
Phase N/A
First received
Last updated
Start date February 1, 2024
Est. completion date June 2028

Study information

Verified date February 2024
Source Johns Hopkins University
Contact Ariana M Chao, PhD, CRNP
Phone 4432876223
Email ariana.chao@jhu.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is a 3-group, parallel design, randomized controlled trial (RCT) in approximately 258 adults with obesity that will investigate whether a 16-week behavioral weight loss treatment and a 52-week stepped-care digital health intervention can improve the maintenance of a ≥ 5% weight loss. 16-week run-in (Phase 1). To qualify for randomization, participants must lose ≥ 5% of initial weight in the 16-week run-in. This loss will be achieved with the provision of weekly-group lifestyle counseling, which includes a partial meal replacement diet. 52-week randomized trial of 3 weight loss maintenance strategies (Phase 2): Participants who have achieved ≥ 5% weight loss during Phase 1 will be randomly assigned to 1 of 3 groups: 1. Participants in the Usual Care group will be emailed monthly educational modules with information on maintaining weight loss. 2. Participants in the SELF group will receive a wireless "smart" body weight scale and a wearable physical activity tracker, and daily text messages with tailored feedback to assist in weight loss maintenance. 3. Participants in the STEP group will be enrolled in an intervention that consists of 4 steps that are progressive and based on response to treatment. After 13 weeks at each step, participants who do not maintain a ≥5% weight loss or regain 2 percentage points of weight from the participants randomization value will move to a higher intensity step. Participants who maintain weight loss will stay at the same step.


Recruitment information / eligibility

Status Recruiting
Enrollment 180
Est. completion date June 2028
Est. primary completion date June 2028
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - BMI>/=30 kg/m2 or >/=27 kg/m2 with an obesity-related complication - Age 18-70 years - Completion of baseline assessment tasks - Ability to engage in physical activity - Own a smartphone capable of receiving text-messages and syncing to weight scales and physical activity trackers - Home wireless access Exclusion Criteria: - Serious medical condition or psychiatric condition that may pose a risk to the participant during intervention, cause a change in weight, or limit ability to adhere to the behavioral recommendations of the program - Pregnant or planning pregnancy in the next 1.5 years - Weight>440 lbs - Planned move out of the area in the next 1.5 years - Recently began a course of or changed the dosage of medication that can cause significant change in weight - History of bariatric surgery - Weight loss of >5% in the previous 6 months - Household member already participating in study

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Usual care
Participants in usual care will be emailed monthly educational modules with information on maintaining weight loss.
SELF
The SELF group will receive a wireless "smart" body weight scale and wearable physical activity tracker, and text messages.
STEP
The STEP intervention consists of 4 steps that are progressive and based on response to treatment. Step 1: Digital health intervention. The first step will be the digital health intervention as described under SELF. Step 2: Monthly, in-person counseling. Participants who move to Step 2 will be provided with monthly, in-person counseling. Step 3: Twice per month counseling. Step 3 will be twice-monthly counseling, spaced at every other week. Step 4: Meal replacements. Participants will be prescribed a partial meal replacement program.

Locations

Country Name City State
United States Johns Hopkins University Baltimore Maryland

Sponsors (2)

Lead Sponsor Collaborator
Johns Hopkins University National Institute of Nursing Research (NINR)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Cost effectiveness To evaluate the incremental cost effectiveness per unit decrease in weight (kg) from a healthcare payer perspective Up to 52 weeks
Primary Weight (kg) change for STEP versus usual care Weight change (kg) for STEP versus usual care Baseline, 52 weeks
Primary Weight (kg) change for SELF versus usual care Weight change (kg) for SELF versus usual care Baseline, 52 weeks
Secondary Change in self-weighing frequency (days) for STEP and SELF versus usual care Change in number of days of self-weighing for STEP and SELF versus usual care Baseline, 52 weeks
Secondary Change in daily calorie intake for STEP and SELF vs usual care Change in daily calorie intake measured using 24-hour dietary recalls for STEP and SELF versus usual care Baseline, 52 weeks
Secondary Change in physical activity (minutes) for STEP and SELF versus usual care Change in self-reported minutes of physical activity for STEP and SELF versus usual care Baseline, 52 weeks
Secondary Weight (kg) change for STEP versus SELF Weight change (kg) for STEP versus SELF Baseline, 52 weeks
Secondary Change in days of self-weighing for STEP versus SELF Self-weighing frequency for STEP versus SELF Baseline, 52 weeks
Secondary Change in daily calorie intake for STEP versus SELF Change in daily calorie intake measured using 24-hour dietary recalls for STEP versus SELF Baseline, 52 weeks
Secondary Change in self-reported minutes of Physical activity for STEP versus SELF Change in self-reported minutes of physical activity for STEP versus SELF Baseline, 52 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2